Bildkälla: Stockfoto

BioInvent: Progress with Oncolytic Virus - Redeye

Redeye comments on the positive results with BT-001 in the phase I study of solid tumours and updates its Base Case.

Redeye comments on the positive results with BT-001 in the phase I study of solid tumours and updates its Base Case.
Börsvärldens nyhetsbrev
ANNONSER